The Food and Drug Administration recently approved a new contact lens for the treatment of corneal edema —an eye condition that causes swelling, fluid build up, blurred vision, haziness and scarring.
The contacts — developed by Israel-based EyeYon — have dual base curves, eight small holes and a reservoir above the center of the cornea to help increase the amount of time eye drops can remain in the eye.The holes in the lens allow prescription eye drops and ointment to slowly seep into the eye under the contact and extract excess fluids from the cornea.
While the contacts do not cure corneal edema, they do offer relief for patients who are on a waitlist for a corneal transplant.
The 14-day disposable lenses cost $50 a pair and are expected to hit the U.S. market in 2017.
More articles on supply chain:
Limited access to pharmacies in rural Oregon linked to hospital readmission
Why laws intended to illuminate drug pricing strategies will likely fail
Opioid overdose drug now offered over the counter at 96 Krogers in Kentucky
[MH1]Could probably combine this paragraph with the next one!